Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,085 | -16,368 | -11,800 | -6,864 | -30,157 |
| Depreciation Amortization | 139 | 105 | 71 | 34 | 1,322 |
| Other Working Capital | -1,592 | -1,878 | -2,347 | -859 | -489 |
| Other Operating Activity | 2,085 | 1,552 | 1,073 | 595 | 4,654 |
| Operating Cash Flow | $-20,453 | $-16,589 | $-13,003 | $-7,094 | $-24,670 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 19,538 | 17,457 | 15,714 | 7,151 | 22,586 |
| PPE Investments | 234 | 234 | 234 | 40 | -146 |
| Investing Cash Flow | $19,772 | $17,691 | $15,948 | $7,191 | $22,440 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 142 | 142 | 142 | N/A | N/A |
| Debt Repayment | -790 | -677 | -525 | -211 | -811 |
| Common Stock Issued | 2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 1 | 1 | 1 | -3 | 24 |
| Financing Cash Flow | $-645 | $-534 | $-382 | $-214 | $-787 |
| Beginning Cash Position | 9,994 | 9,994 | 9,994 | 9,994 | 13,011 |
| End Cash Position | 8,668 | 10,562 | 12,557 | 9,877 | 9,994 |
| Net Cash Flow | $-1,326 | $568 | $2,563 | $-117 | $-3,017 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,453 | -16,589 | -13,003 | -7,094 | -24,670 |
| Capital Expenditure | -16 | -16 | -16 | N/A | -146 |
| Free Cash Flow | -20,469 | -16,605 | -13,019 | -7,094 | -24,816 |